The success of Sildenafil initially fueled a period of growth for the drug industry, nevertheless recent developments present a uncertain scenario for shareholders. Off-patent alternatives are eating into revenue, and https://deannaqmzz113985.link4blogs.com/62019596/viagra-and-pharma-a-volatile-bet